The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients...

Risk of blood clots increases with the amount of time spent watching television, even if people get the recommended amount of physical activity, according to preliminary research presented at the American...